The New AI-Mediated Treatment Journey: How Patient and HCP AI Are Rewriting Pharma Commercial Strategy

Session details:

Patients and HCPs increasingly use different AI systems to understand conditions, compare treatments, interpret evidence, and prepare for decisions. Using research with 50 patients, 10–15 HCPs, and data from both patient and clinical AI environments, this talk examines where these two information journeys converge, where they conflict, and what this means for brand strategy, evidence communication, access, and commercial investment.